Abstract
Aberrantly hypermethylated genes in human lung cancers were searched for by a genome scanning technique, methylation-sensitive-representational difference analysis (MS-RDA). A total of 59 DNA fragments were isolated as those methylated more heavily in either/both of two lung squamous cell carcinoma cell lines, EBC-1 and LK-2, than in a primary culture of normal human bronchial epithelium, NHBE. Thirty-four DNA fragments, whose hypermethylation was confirmed in primary squamous cell carcinomas, were sequenced. By database searches, 17 of them were shown to be located within 2 kb of putative CpG islands, and five of the 17 DNA fragments had transcribed regions of known genes in their vicinities. By RT–PCR of the five genes in the carcinoma cell lines and NHBE, decreased expression of HTR1B (5-hydroxytryptamine receptor 1B) and EDN1 (endothelin-1) was observed. Sequencing after bisulfite modification showed that the CpG island in the promoter region of HTR1B was hypermethylated, while that of EDN1 was not. Demethylation and re-expression of HTR1B were observed after treatment of LK-2 cells with 5-aza-2′-deoxycytidine. In primary lung cancers, decreased mRNA expression of HTR1B was observed in 11 of 20 cases, and that of EDN1 was in 16 of 20 cases. Immunohistochemical analysis of endothelin-1 confirmed that its immunoreactivity was reduced in squamous cell carcinoma cells compared with that in normal bronchial epithelial cells. Considering that endothelin-1 induces apoptosis in melanoma cells and that silencing of endothelin receptor B is observed in prostate cancers, its reduced expression was speculated to confer a growth advantage to lung cancer cells. MS-RDA was shown to isolate DNA fragments that are hypermethylated and silenced, such as HTR1B, and those whose expressions are altered and the methylation statuses outside the promoter region are altered, such as EDN1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Al Moustafa AE, Yansouni C, Alaoui-Jamali MA, O'Connor-McCourt M . 1999 Clin. Cancer Res. 5: 681–686
Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP . 1998 Adv. Cancer Res. 72: 141–196
Costello JF, Futscher BW, Tano K, Graunke DM, Pieper RO . 1994 J. Biol. Chem. 269: 17228–17237
Demchyshyn L, Sunahara RK, Miller K, Teitler M, Hoffman BJ, Kennedy JL, Seeman P, Van Tol HH, Niznik HB . 1992 Proc. Natl. Acad. Sci. USA 89: 5522–5526
Eguchi K, Kanai Y, Kobayashi K, Hirohashi S . 1997 Cancer Res. 57: 4913–4915
Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD, Coligan JE, Kehrl JH, Fauci AS . 1990 J. Exp. Med. 172: 1741–1748
Gardiner-Garden M, Frommer M . 1987 J. Mol. Biol. 196: 261–282
Harris CC, Reddel R, Pfeifer A, Iman D, McMenamin M, Trump BF, Weston A . 1991 IARC Sci. Publ. 105: 294–304
Henke W, Herdel K, Jung K, Schnorr D, Loening SA . 1997 Nucleic Acids Res. 25: 3957–3958
Jakowlew SB, Mariano JM, You L, Mathias A . 1997 Biochim. Biophys. Acta. 1353: 157–170
Jones PA, Laird PW . 1999 Nat. Genet. 21: 163–167
Kadokami Y, Lewis RV . 1995 Anal. Biochem. 226: 193–195
Kelsey G, Bodle D, Miller HJ, Beechey CV, Coombes C, Peters J, Williamson CM . 1999 Genomics 62: 129–138
Larsen F, Gundersen G, Lopez R, Prydz H . 1992 Genomics 13: 1095–1107
Markewitz BA, Kohan DE, Michael JR . 1995 Am. J. Physiol. 268: L192–L200
Masaki T, Yanagisawa M, Goto K . 1992 Med. Res. Rev. 12: 391–421
Mattoli S, Mezzetti M, Riva G, Allegra L, Fasoli A . 1990 Am. J. Respir. Cell. Mol Biol. 3: 145–151
McDowell DG, Burns NA, Parkes HC . 1998 Nucleic Acids Res. 26: 3340–3347
Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D . 1995 Nat. Met. 1: 686–692
Moghal N, Neel BG . 1998 Mol. Cell. Biol. 18: 6666–6678
Nelson JB, Chan-Tack K, Hedican SP, Magnuson SR, Opgenorth TJ, Bova GS, Simons JW . 1996 Cancer Res. 56: 663–668
Nelson JB, Lee WH, Nguyen SH, Jarrard DF, Brooks JD, Magnuson SR, Opgenorth TJ, Nelson WG, Bova GS . 1997 Cancer Res. 57: 35–37
Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG . 1999 Proc. Natl. Acad. Sci. USA 96: 12754–12759
Okazawa M, Shiraki T, Ninomiya H, Kobayashi S, Masaki T . 1998 J. Biol. Chem. 273: 12584–12592
Rein T, Zorbas H, DePamphilis ML . 1997 Mol. Cell. Biol. 17: 416–426
Sambrook J, Russel DW . 2000 Molecular Cloning, 3rd edn Cold Spring Harbor Laboratory Press, New York
Sekido Y, Fong KM, Minna JD . 1998 Biochim. Biophys. Acta. 1378: F21–F59
Sengupta PK, Smith BD . 1998 Biochim. Biophys. Acta. 1443: 75–89
Sugimura T, Ushijima T . 2000 Mutat. Res. 462: 235–246
Ushijima T, Morimura K, Hosoya Y, Okonogi H, Tatematsu M, Sugimura T, Nagao M . 1997 Proc. Natl. Acad. Sci. USA 94: 2284–2289
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T . 1988 Nature 332: 411–415
Acknowledgements
The authors are grateful to Drs T Niki and T Yamada for providing tumor samples and preparing paraffin block sections; to Dr M Nagao for supportive discussions; and to Drs T Kuramoto and K Asada for critical reading of the manuscript. D Takai is a recipient of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research. This study was supported by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare; by a Grant-in-Aid for Human Genome and Gene Therapy; by a Grant-in-Aid from the Ministry of Education, Science, Culture and Sports; and by a grant from the Hishinomi Foundation for Cancer Research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takai, D., Yagi, Y., Wakazono, K. et al. Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis. Oncogene 20, 7505–7513 (2001). https://doi.org/10.1038/sj.onc.1204940
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204940
Keywords
This article is cited by
-
Arsenic-mediated hyperpigmentation in skin via NF-kappa B/endothelin-1 signaling in an originally developed hairless mouse model
Archives of Toxicology (2017)
-
Bioinformatic analyses revealed underlying biological functions correlated with oxaliplatin responsiveness
Tumor Biology (2016)
-
Transcriptional profiling revealed the anti-proliferative effect of MFN2 deficiency and identified risk factors in lung adenocarcinoma
Tumor Biology (2016)
-
Discovery of prognostic biomarkers for predicting lung cancer metastasis using microarray and survival data
BMC Bioinformatics (2015)
-
Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features
BMC Cancer (2010)